CD4+ T cell counts and soluble programmed death-1 at baseline correlated with hepatitis B surface antigen decline in HIV/HBV coinfection during combined antiretroviral therapy

CD4+ T cell counts and soluble programmed death-1 at baseline correlated with hepatitis B surface antigen decline in HIV/HBV coinfection during combined antiretroviral therapy

BackgroundSeveral studies have described the rapid decline and clearance of hepatitis B surface antigen (HBsAg) in human immunodeficiency virus (HIV)/hepatitis B virus (HBV) coinfection after initiating combined antiretroviral therapy (cART). Early decline of HBsAg levels is associated with HBsAg se...

Full description

Bibliographic Details
Main Authors:	Xiaodi Li, Ling Xu, Lianfeng Lu, Xiaosheng Liu, Yang Yang, Yuanni Wu, Yang Han, Xiaoxia Li, Yanling Li, Xiaojing Song, Wei Cao, Taisheng Li
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2023-05-01
Series:	Frontiers in Cellular and Infection Microbiology
Subjects:	coinfection HIV HBV HBsAg decline soluble PD-1 immune activation
Online Access:	https://www.frontiersin.org/articles/10.3389/fcimb.2023.1178788/full

Similar Items

Unexpected rise in the circulation of complex HBV variants enriched of HBsAg vaccine-escape mutations in HBV genotype-D: potential impact on HBsAg detection/quantification and vaccination strategies
by: Lorenzo Piermatteo, et al.
Published: (2023-12-01)

Epidemiological characteristics of acute HBV infection
by: Perić Valerija, et al.
Published: (2019-01-01)

Analysis of S gene characteristic sequences and changes in properties of protein expression in HBV ASCs with low-level HBsAg
by: Yu Yu, et al.
Published: (2022-09-01)

Key mutations in the C-terminus of the HBV surface glycoprotein correlate with lower HBsAg levels in vivo, hinder HBsAg secretion in vitro and reduce HBsAg structural stability in the setting of HBeAg-negative chronic HBV genotype-D infection
by: Romina Salpini, et al.
Published: (2020-01-01)

Age-wise and Gender-wise Prevalence of Hepatitis B Virus (HBV) Infection in Lahore, Pakistan
by: Aqib Nazeer, et al.
Published: (2019-12-01)

Seroprevalence of HIV-HBV Co-Infection
by: Suresh B. Sonth, et al.
Published: (2012-04-01)

Lower pretreatment HBV DNA levels are associated with better off-treatment outcomes after nucleo(s)tide analogue withdrawal in patients with HBeAg-neegative chronic hepatitis B: A multicentre cohort study
by: Milan J. Sonneveld, et al.
Published: (2023-08-01)

Intrahepatic quantification of HBV antigens in chronic hepatitis B reveals heterogeneity and treatment-mediated reductions in HBV core-positive cells
by: Abhishek Aggarwal, et al.
Published: (2023-04-01)

Pre-transplant donor HBV DNA+ and male recipient are independent risk factors for treatment failure in HBsAg+ donors to HBsAg- kidney transplant recipients
by: Xian-ding Wang, et al.
Published: (2021-01-01)

Occult HBV infection
by: Mariangela Spinosa, et al.
Published: (2010-09-01)

Investigation of HBV DNA in HBsAg positive patients
by: Nihal Secil Bati, et al.
Published: (2017-12-01)

Distinct patterns of serum hepatitis B core-related antigen during the natural history of chronic hepatitis B
by: Zhan-Qing Zhang, et al.
Published: (2017-12-01)

Epidemiology of Chronic Hepatitis B Infection in the Cohort of College Students with Vaccination in Taiwan
by: Te-Wei Cheng, et al.
Published: (2023-02-01)

In situ analysis of hepatitis B virus (HBV) antigen and DNA in HBV-induced hepatocellular carcinoma
by: Ye Zheng, et al.
Published: (2022-01-01)

ADCC-Mediated CD56dim NK Cell Responses Are Associated with Early HBsAg Clearance in Acute HBV Infection
by: Wen-Han Yu, et al.
Published: (2018-02-01)

[Use of tenofovir monotherapy in a cohort of prisoners confined in the prisons of the Molise region and affected by mild HBV-related chronic hepatitis]
by: Roberto Patriarchi, et al.
Published: (2015-12-01)

Short-Term Peg-IFN α-2b Re-Treatment Induced a High Functional Cure Rate in Patients with HBsAg Recurrence after Stopping Peg-IFN α-Based Regimens
by: Fengping Wu, et al.
Published: (2023-01-01)

Hepatitis B Virus Reactivation upon Immunosuppression: Is There a Role for Hepatitis B Core-Related Antigen in Patients with Immune-Escape Mutants? A Case Report
by: Gian Paolo Caviglia, et al.
Published: (2021-11-01)

Impact of HBcrAg levels on HBsAg seroconversion after HBV rebound: a case report
by: Maki Ohkubo, et al.
Published: (2023-12-01)

Antigen Load and T Cell Function: A Challenging Interaction in HBV Infection
by: Ilaria Montali, et al.
Published: (2022-05-01)

Is Quantitative HBsAg Measurement a Reliable Substitute for HBV DNA Quantitation?
by: Mohammad Reza Mahdavi, et al.
Published: (2015-07-01)

Prediction for HBsAg seroconversion in children with chronic hepatitis B
by: Yan-Wei Zhong, et al.
Published: (2021-12-01)

Using the Quantitative Determination of HbsAg to Monitor Antiviral Therapy of Chronic HBV-Infection
by: I.A. Zaitsev
Published: (2015-04-01)

The relationship between polymorphisms in intron 8 of vitamin D receptor gene and occult HBV infection
by: Rezvani ME, et al.
Published: (2009-08-01)

The occurrence of immune-related adverse events is an independent risk factor both for serum HBsAg increase and HBV reactivation in HBsAg-positive cancer patients receiving PD-1 inhibitor combinational therapy
by: Yingfu Zeng, et al.
Published: (2024-03-01)

Detection and prevalence of HBsAg and HBV DNA among visiting patients attending health facilities in Nigeria
by: Uchenna D. Abazuh, et al.
Published: (2023-07-01)

Levels of HBV RNA in chronic HBV infected patients during first-line nucleos(t)ide analogues therapy
by: Bei Jiang, et al.
Published: (2022-12-01)

Host immunity and HBV S gene mutation in HBsAg-negative HBV-infected patients
by: Xin Liu, et al.
Published: (2023-08-01)

Hepatitis B Virus Chronic Infection in Blood Donors from Asian and African High or Medium Prevalence Areas: Comparison According to Sex
by: Jean-Pierre Allain, et al.
Published: (2022-03-01)

Immune-escape mutations and stop-codons in HBsAg develop in a large proportion of patients with chronic HBV infection exposed to anti-HBV drugs in Europe
by: Luna Colagrossi, et al.
Published: (2018-06-01)

A Comparative study on the prevalence of HCC seromarkers among tribal and coastal population
by: Joseph Selvin, et al.
Published: (2010-03-01)

Prevalence of HBV genotypes in South American immigrants affected by HBV-related chronic active hepatitis
by: Emilio Palumbo, et al.

Comparison of hepatitis B viral loads and viral antigen levels in child-bearing age women with and without pregnancy
by: Chenyu Xu, et al.
Published: (2018-07-01)

Pimobendan Inhibits HBV Transcription and Replication by Suppressing HBV Promoters Activity
by: Si-Yu Yuan, et al.
Published: (2022-06-01)

Clinical Outcomes and Quantitative HBV Surface Antigen Levels in Diverse Chronic Hepatitis B Patients in Canada: A Retrospective Real-World Study of CHB in Canada (REVEAL-CANADA)
by: Carla S. Coffin, et al.
Published: (2022-11-01)

An optimized mode of interferon intermittent therapy help improve HBsAg disappearance in chronic hepatitis B patients
by: Minghui Li, et al.
Published: (2022-08-01)

Risk stratification of HBV infection in Asia-Pacific region
by: Jia-Horng Kao
Published: (2014-09-01)

The Progress of Anti-HBV Constituents from Medicinal Plants in China
by: Chang-An Geng, et al.
Published: (2018-07-01)

Hepatitis B virus infections among health professional students in Mwanza city,Tanzania in 2016
by: Mariam M. Mirambo, et al.
Published: (2020-08-01)

Molecular and Genetic Characterization of Hepatitis B Virus (HBV) among Saudi Chronically HBV-Infected Individuals
by: Mariantonietta Di Stefano, et al.
Published: (2023-02-01)